← Open Payments lookup

REBECCA SMITH: Open Payments

NPI 1841707270 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$374 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $162 · 2025 $374

Food & beverage: $374
CompanyPaymentsAmount
Novo Nordisk Inc1$71
Otsuka America Pharmaceutical, Inc.3$57
Vanda Pharmaceuticals Inc.3$54
Janssen Pharmaceuticals, Inc2$52
Lundbeck LLC2$34
ABBVIE INC.2$33
Alkermes, Inc.1$31
Lilly USA, LLC1$22
Neurocrine BioSciences, Inc.1$20

Products named: REXULTI, Wegovy, HETLIOZ, SPRAVATO, VRAYLAR, ARISTADA, ZEPBOUND, INGREZZA.

Industry payments across MD — which companies pay providers there.